Pfizer Inc

Pfizer increases its drugs prices including Lyrica and Viagra

Pfizer today confirmed that the company has increased the price of some of its drugs although it was not revealed how many drugs are involved with the price hike. According to a data by Wolters Kluwer which revealed that more than 100 types of drugs has been increased in its price starting on January 1st.

Read Full Article

Pfizer's Arthritis Drug Patent Rejected in India

Pfizer Inc. has failed again in enforcing its intellectual property rights in India. The giant pharmaceutical's patent on its rheumatoid arthritis drug, Tofacitinib, was rejected in the country.

Read Full Article

Investors seek protection against healthcare stock decline

Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

Read Full Article

Biogen shortens name, expands ambitions in Alzheimer's, ALS

Biogen Idec Inc has seen its market value quadruple in three years to more than $100 billion on the back of its successful multiple sclerosis drugs. Now it has new ambitions in its sights.

Read Full Article

Pfizer bets on gene therapy as technology comes of age

Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.

Read Full Article

Pfizer beats sales and profit forecasts, mum on future deals

Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans following its recent failed efforts to buy rival British drugmaker AstraZeneca Plc (AZN.L).

Read Full Article

Pfizer-AstraZeneca acquisition talks halted, no plan to resume - Sources

The deal between Pfizer and AstraZeneca to acquire its London based business were halted with no plans to resume said sources who spoke in condition of anonymity as the matter was held private in nature.

Read Full Article

Drug majors Novartis, Merck in talks to trade business units

Pharma giants Novartis International AG and Merck & Co. Inc. are reportedly negotiating an asset trade of about $5 billion each. Novartis wants to exchange its animal health and human vaccines businesses for Merck's over-the-counter health products unit.

Read Full Article

Indian units of Pfizer and Wyeth to merge

Pfizer Ltd, the Indian unit of U.S. drug maker Pfizer Inc, is to take over local affiliate Wyeth Ltd. Shareholders of Wyeth will get seven Pfizer Ltd shares for every 10 shares held.

Read Full Article

Pfizer Ltd to take over Wyeth Ltd

A Saturday announcement revealed that Pfizer Ltd, Pfizer Inc's Indian unit, would be merging with its local affiliate Wyeth Ltd after both pharmaceutical firms' boards approved the deal.

Read Full Article

Novartis and Pfizer, Added Potential Bidders for Onyx

Pharmaceutical companies Novartis and Pfizer showing interest in Onyx

Read Full Article

Kerry to divest some holdings if confirmed as US secretary of state

U.S. Senator John Kerry and his wife intend to divest holdings in dozens of companies to avoid conflicts of interest if he is confirmed as U.S. secretary of state

Read Full Article

Former Pfizer CEO Kindler joins Lux Capital

Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics